Atomera Inc: Form 10-Q for the period ended Sep 30, 2021
Filed with the SEC on Nov 1, 2021 and accepted by EDGAR at Nov 1, 2021, 16:47 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2021-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2021-07-01 to 2021-09-30 | $0 | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2021-01-01 to 2021-09-30 | $400.0k | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2021-07-01 to 2021-09-30 | $0 | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2021-01-01 to 2021-09-30 | $0 | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2021-07-01 to 2021-09-30 | $0 | us-gaap:GrossProfit |
| Gross profit | 9 months2021-01-01 to 2021-09-30 | $400.0k | us-gaap:GrossProfit |
| Research and development | 3 months2021-07-01 to 2021-09-30 | $2.2m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2021-01-01 to 2021-09-30 | $6.5m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2021-07-01 to 2021-09-30 | −$4.1m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2021-01-01 to 2021-09-30 | −$11.5m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2021-07-01 to 2021-09-30 | $52.0k | us-gaap:InterestExpense |
| Interest expense | 9 months2021-01-01 to 2021-09-30 | $52.0k | us-gaap:InterestExpense |
| Income tax | 3 months2021-07-01 to 2021-09-30 | $17.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2021-01-01 to 2021-09-30 | $48.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2021-07-01 to 2021-09-30 | −$4.2m | us-gaap:NetIncomeLoss |
| Net income | 9 months2021-01-01 to 2021-09-30 | −$11.5m | us-gaap:NetIncomeLoss |
| Operating cash flow | 9 months2021-01-01 to 2021-09-30 | −$9.4m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2021-01-01 to 2021-09-30 | $102.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2021-09-30 | $31.8m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2021-09-30 | $32.2m | us-gaap:AssetsCurrent |
| Total assets | At period end2021-09-30 | $39.7m | us-gaap:Assets |
| Current liabilities | At period end2021-09-30 | $2.9m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2021-09-30 | $8.2m | us-gaap:Liabilities |
| Shareholders' equity | At period end2021-09-30 | $31.5m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001683168-21-005174. Last ingested by Listed: Nov 5, 2026, 02:11 ET. Listed shows no prices and gives no investment advice.